Photoactivatable Caged Prodrugs of VEGFR-2 Kinase Inhibitors.

Molecules

Institute of Pharmacy, University of Kiel, Gutenbergstr. 76, D-24118 Kiel, Germany.

Published: April 2016

In this study, we report on the design, synthesis, photokinetic properties and in vitro evaluation of photoactivatable caged prodrugs for the receptor tyrosine kinase VEGFR-2. Highly potent VEGFR-2 inhibitors 1 and 3 were caged by introduction of a photoremovable protecting group (PPG) to yield the caged prodrugs 4 and 5. As expected, enzymatic and cellular proliferation assays showed dramatically diminished efficacy of caged prodrugs in vitro. Upon ultraviolet (UV) irradiation of the prodrugs original inhibitory activity was completely restored and even distinctly reinforced, as was the case for the prodrug 4. The presented results are a further evidence for caging technique being an interesting approach in the protein kinase field. It could enable spatial and temporal control for the inhibition of VEGFR-2. The described photoactivatable prodrugs might be highly useful as biological probes for studying the VEGFR-2 signal transduction.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274539PMC
http://dx.doi.org/10.3390/molecules21050570DOI Listing

Publication Analysis

Top Keywords

caged prodrugs
16
photoactivatable caged
8
prodrugs
6
vegfr-2
5
prodrugs vegfr-2
4
vegfr-2 kinase
4
kinase inhibitors
4
inhibitors study
4
study report
4
report design
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!